Viewing nowCombinationDubika Tablet 5/20mg
Olmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Sama Pharmaceutical Co., Ltd.

MFDS item code 201500292 · Approved 2015.01.20
Treatment of essential hypertension not controlled with monotherapy
Amlodipine or Olmesartan Medoxomil is used when blood pressure control is difficult in patients with essential hypertension. These two medications work by relaxing blood vessels to lower blood pressure. Proper blood pressure management is important to reduce the risk of cardiovascular diseases and improve overall health. Especially when blood pressure is not controlled through monotherapy, these medications help effectively manage blood pressure. Therefore, these medications can be used to manage blood pressure reliably in the treatment of essential hypertension.
Take 1 tablet once daily with water, regardless of meals. If possible, it is recommended to take it at the same time every day (e.g., in the morning). Before starting this medication, it is recommended to adjust the dose using the individual components (amlodipine or olmesartan medoxomil). However, if blood pressure is not adequately controlled with monotherapy using either component, switching directly to this medication may be considered. The maximum dose of this medication is 10/40 milligrams. The maximum blood pressure-lowering effect occurs within 2 weeks after administration; therefore, adjust the dose at intervals of 2 weeks or longer, taking the patient's blood pressure response into consideration. The recommended doses are as follows. - 5/20 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or olmesartan medoxomil 20 milligrams as monotherapy. - 10/20 milligrams: For patients whose blood pressure is not adequately controlled with olmesartan medoxomil 20 milligrams as monotherapy. - 5/40 milligrams: For patients whose blood pressure is not adequately controlled with 5/20 milligrams. - 10/40 milligrams: For patients whose blood pressure is not adequately controlled with 5/40 milligrams. ∘Patients with renal impairment: This medication has not been studied in patients with renal impairment. However, the maximum dose of olmesartan medoxomil in patients with mild to moderate renal impairment (creatine clearance 20-60mL/min) is 20 milligrams once daily, and use of this medication is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients receiving dialysis. Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. ∘Patients with reduced effective intravascular volume: In patients who may have reduced effective intravascular volume (Intravascular volume depletion) (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended to start treatment at a low dose while closely monitoring their condition. ∘Patients with hepatic impairment: Use with caution in patients with mild to moderate hepatic impairment. The recommended initial dose of olmesartan medoxomil in patients with moderate hepatic impairment is 10 milligrams once daily, and the maximum dose is 20 milligrams once daily. Patients with hepatic impairment who are already receiving other antihypertensive drugs and/or diuretics should be closely monitored for blood pressure and renal function. This medication must not be administered to patients with severe hepatic impairment. (See Precautions for Use, section 2, Do not administer to the following patients.) ∘Elderly patients: In general, start treatment at a low dose. When adjusting the dose, consider the patient's renal or cardiac function and comorbidities. In elderly patients, blood pressure should be monitored closely and more frequently.
Pediatric patients under 18 years of age: Safety and efficacy have not been established.
This medication should not be taken during the second and third trimesters of pregnancy, as it can cause serious harm to the fetus and newborn. If pregnancy is confirmed, discontinue immediately. Do not take this medication if you have allergies to any of its components or similar drugs, if you are pregnant or breastfeeding, if you have severe liver disease or aortic stenosis, if you have biliary obstruction, if you are undergoing kidney dialysis, if you are in a state of shock, or if you have certain diabetes or significantly impaired kidney function. Patients with dehydration or low salt levels, those with low blood pressure, those with severe cardiovascular diseases, heart failure patients, and those with poor kidney or liver function should use this medication cautiously and consult healthcare professionals immediately if symptoms of hypotension or other abnormal symptoms occur. This medication may cause various side effects such as dizziness, headaches, hypotension, edema, dyspepsia, and rashes; notify healthcare professionals immediately if symptoms worsen or abnormal reactions occur. Particularly, this medication can increase blood potassium levels; hence, potassium levels should be monitored frequently when taken with potassium supplements or potassium-sparing diuretics. Drug interactions may occur when this medication is taken with other antihypertensives, diuretics, non-steroidal anti-inflammatory drugs, certain antibiotics, etc.; inform healthcare professionals of all medications being taken. Women who are pregnant or planning to become pregnant should consult healthcare professionals before using this medication, and discontinue immediately if pregnancy is confirmed. Breastfeeding women should consult healthcare professionals about whether to continue breastfeeding or stop taking the medication, as this medication can be partially transmitted through breast milk. Safety in children and adolescents under 18 years of age has not been established, and it is not recommended. Elderly patients may have reduced kidney or liver function, so dosage adjustment and caution are needed when taking this medication. In case of overdose, severe hypotension or cardiac arrhythmias may occur; immediate emergency treatment is required in such cases. This medication should be stored in a tightly closed container to prevent air or moisture from entering, out of reach of children, and it is advisable not to transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture from entering. It is important to maintain a storage temperature between 1 and 30 degrees Celsius to preserve the effectiveness of the medication.
White round film-coated tablet
28 tablets/box [14 tablets/PTP x 2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Sama Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
Co., Ltd. Sainex
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.